dextroamphetamine has been researched along with Psychoses, Drug in 40 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Excerpt | Relevance | Reference |
---|---|---|
"One of the most devastating consequences of methamphetamine abuse is increased risk of psychosis." | 3.83 | BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine. ( Halberstadt, AL; Manning, EE; van den Buuse, M, 2016) |
" While medications for ADHD are generally well-tolerated, there are common, although less severe, as well as rare but severe adverse events AEs during treatment with ADHD drugs." | 2.49 | Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. ( Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (62.50) | 18.7374 |
1990's | 5 (12.50) | 18.2507 |
2000's | 4 (10.00) | 29.6817 |
2010's | 5 (12.50) | 24.3611 |
2020's | 1 (2.50) | 2.80 |
Authors | Studies |
---|---|
Kooij, JJS | 1 |
Gomes, CAB | 1 |
Mahgoub, Y | 1 |
Manning, EE | 1 |
Halberstadt, AL | 1 |
van den Buuse, M | 1 |
Steinkellner, T | 1 |
Freissmuth, M | 1 |
Sitte, HH | 1 |
Montgomery, T | 1 |
Hirthler, MA | 1 |
Cortese, S | 1 |
Holtmann, M | 1 |
Banaschewski, T | 1 |
Buitelaar, J | 1 |
Coghill, D | 1 |
Danckaerts, M | 1 |
Dittmann, RW | 1 |
Graham, J | 1 |
Taylor, E | 1 |
Sergeant, J | 1 |
Martin, RS | 1 |
Secchi, RL | 1 |
Sung, E | 1 |
Lemaire, M | 1 |
Bonhaus, DW | 1 |
Hedley, LR | 1 |
Lowe, DA | 1 |
Spear, J | 1 |
Alderton, D | 1 |
KEITER, WE | 1 |
ARNOLD, JH | 1 |
BACHRICH, PR | 1 |
PROUT, CT | 1 |
FORREST, AD | 1 |
Calello, DP | 1 |
Osterhoudt, KC | 1 |
Andersen, MB | 1 |
Werge, T | 1 |
Fink-Jensen, A | 1 |
Ellison, GD | 1 |
Eison, MS | 1 |
Nielsen, EB | 1 |
Lyon, M | 1 |
Ellison, G | 2 |
Schiørring, E | 1 |
Segal, DS | 2 |
Kuczenski, R | 1 |
Robinson, TE | 1 |
Kolb, B | 1 |
Borowski, TB | 1 |
Kokkinidis, L | 1 |
Gold, MS | 1 |
Bowers, MB | 1 |
Angrist, B | 3 |
Gershon, S | 3 |
Oviasu, VO | 1 |
Allen, RP | 1 |
Safer, D | 1 |
Covi, L | 1 |
Sanfilipo, M | 1 |
Wolkin, A | 1 |
Lipton, J | 1 |
Zeigler, S | 1 |
Wilkins, J | 1 |
Ando, K | 1 |
Hironaka, N | 1 |
Yanagita, T | 1 |
van Kammen, DP | 1 |
Docherty, JP | 1 |
Marder, SR | 1 |
Rosenblatt, JE | 1 |
Bunney, WE | 1 |
Greenberg, BD | 1 |
Sathananthan, G | 1 |
Wilk, S | 1 |
Eisenberg, L | 1 |
Griffith, JD | 1 |
Cavanaugh, J | 1 |
Held, J | 1 |
Oates, JA | 1 |
Greenberg, LM | 1 |
Deem, MA | 1 |
McMahon, S | 1 |
Snyder, SH | 1 |
Aghajanian, GK | 1 |
Matthysse, S | 1 |
West, AP | 1 |
Ellinwood, EH | 1 |
Cohen, S | 1 |
Angrist, BM | 1 |
Shopsin, B | 1 |
Randrup, A | 1 |
Munkvad, I | 1 |
Todd, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Therapeutic Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Pediatric Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Cohorts (ADHD): a Randomized, Sham-controlled Study.[NCT06069323] | 80 participants (Anticipated) | Interventional | 2023-06-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for dextroamphetamine and Psychoses, Drug
Article | Year |
---|---|
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
Topics: Amphetamines; Animals; Dextroamphetamine; Humans; Methamphetamine; Mitochondria; Molecular Structure | 2011 |
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure | 2013 |
Effects of psychostimulants on aggression.
Topics: Adolescent; Aggression; Amphetamine; Animals; Child; Dextroamphetamine; Dogs; Dose-Response Relation | 1975 |
4 trials available for dextroamphetamine and Psychoses, Drug
Article | Year |
---|---|
Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.
Topics: Adolescent; Adult; Analysis of Variance; Dextroamphetamine; Euphoria; Female; Humans; Lithium; Male; | 1985 |
Dextroamphetamine. Evaluation of psychomimetic properties in man.
Topics: Administration, Oral; Adult; Catecholamines; Central Nervous System; Clinical Trials as Topic; Depre | 1972 |
Effects of dextroamphetamine, chlorpromazine, and hydroxyzine on behavior and performance in hyperactive children.
Topics: Child; Chlorpromazine; Clinical Trials as Topic; Depression; Dextroamphetamine; Dose-Response Relati | 1972 |
Amphetamine abuse.
Topics: Acetylcholinesterase; Aggression; Amphetamine; Animals; Antisocial Personality Disorder; Behavior, A | 1971 |
33 other studies available for dextroamphetamine and Psychoses, Drug
Article | Year |
---|---|
[Risk of psychosis with treatment for ADHD].
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; | 2020 |
Caffeine-Induced Psychosis in a Bodybuilder With Chronic Testosterone and Amphetamine/Dextroamphetamine Misuse.
Topics: Amphetamine; Caffeine; Dextroamphetamine; Humans; Male; Middle Aged; Performance-Enhancing Substance | 2018 |
BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Central Nervous System St | 2016 |
Change of shift. Of masses and men.
Topics: Amphetamine-Related Disorders; Dextroamphetamine; Emergency Service, Hospital; Female; Humans; Physi | 2011 |
Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
Topics: Animals; Antipsychotic Agents; Apomorphine; Arousal; Attention; Behavior, Animal; Cyclohexanols; Dex | 2003 |
Psychosis associated with prescribed dexamphetamine use.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; | 2003 |
Acute dexedrine intoxication in children.
Topics: Amphetamine; Central Nervous System Agents; Child; Dextroamphetamine; Drug-Related Side Effects and | 1955 |
NEW DRUGS OF ADDICTION?
Topics: Adolescent; Amobarbital; Barbiturates; Behavior, Addictive; Dextroamphetamine; Lysergic Acid Diethyl | 1964 |
REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL.
Topics: Alcoholism; Amobarbital; Amphetamine; Amphetamines; Barbiturates; Dextroamphetamine; Hospitals, Psyc | 1964 |
DRUGS FOR DEPRESSION.
Topics: Amobarbital; Antidepressive Agents; Chlordiazepoxide; Depression; Depressive Disorder; Dextroampheta | 1964 |
Acute psychosis associated with therapeutic use of dextroamphetamine.
Topics: Acute Disease; Central Nervous System Stimulants; Child; Dextroamphetamine; Humans; Male; Psychoses, | 2004 |
The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys.
Topics: Animals; Arousal; Behavior, Animal; Cebus; Cholinesterase Inhibitors; Dextroamphetamine; Dyskinesia, | 2007 |
Continuous amphetamine intoxication: an animal model of the acute psychotic episode.
Topics: Animals; Behavior, Animal; Caudate Nucleus; Dextroamphetamine; Disease Models, Animal; Dopamine; Hal | 1983 |
Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis.
Topics: Animals; Behavior, Animal; Chlorocebus aethiops; Dextroamphetamine; Drug Implants; Grooming; Halluci | 1983 |
Psychopathology induced by "speed drugs".
Topics: Animals; Behavior; Behavior, Animal; Chlorocebus aethiops; Dextroamphetamine; Female; Humans; Male; | 1981 |
An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.
Topics: Animals; Brain; Caudate Nucleus; Dextroamphetamine; Disease Models, Animal; Dopamine; Dose-Response | 1997 |
Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain Damage, Chronic; Central Nervous System Stimulants; De | 1997 |
The effects of cocaine, amphetamine, and the dopamine D1 receptor agonist SKF 38393 on fear extinction as measured with potentiated startle: implications for psychomotor stimulant psychosis.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acoustic Stimulation; Analysis of Varian | 1998 |
Neurobiological vulnerability to low-dose amphetamine psychosis.
Topics: Adult; Dextroamphetamine; Disease Susceptibility; Dopamine; Dose-Response Relationship, Drug; Female | 1978 |
Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects.
Topics: Amphetamine; Dextroamphetamine; Dopamine; Humans; Levodopa; Male; Paranoid Disorders; Piribedil; Psy | 1977 |
Abuse of stimulant drugs in Nigeria.
Topics: Adolescent; Adult; Anxiety; Caffeine; Dextroamphetamine; Drug Synergism; Female; Humans; Male; Niger | 1976 |
Amphetamine response and duration of illness in schizophrenia.
Topics: Adult; Aged; Dextroamphetamine; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neurocognit | 1991 |
A silicone pellet for continuous cocaine: comparison with continuous amphetamine.
Topics: Animals; Behavior, Animal; Cocaine; Dextroamphetamine; Disease Models, Animal; Drug Implants; Male; | 1991 |
Psychotic manifestations in amphetamine abuse--experimental study on the mechanism of psychotic recurrence.
Topics: Animals; Conditioning, Operant; Dextroamphetamine; Disease Models, Animal; Male; Methamphetamine; Mi | 1986 |
Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors.
Topics: Animals; Behavior, Animal; Dextroamphetamine; Drug Interactions; Humans; Male; Motor Activity; Phenc | 1985 |
Amphetamine psychosis: behavioral and biochemical aspects.
Topics: Adolescent; Adult; Affect; Alcoholism; Amphetamine; Brain; Cognition Disorders; Delusions; Depressio | 1974 |
Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Feeding and Eat | 1972 |
Amphetamine-type drugs for hyperactive children.
Topics: Appetite; Attention Deficit Disorder with Hyperactivity; Body Weight; Brain; Child; Dextroamphetamin | 1972 |
Prospects for research on schizophrenia. V. Pharmacological observations, Drug-induced psychoses.
Topics: Animals; Brain; Brain Chemistry; Chlorpromazine; Dextroamphetamine; Dopamine; Humans; Limbic System; | 1972 |
Interaction of low-dose amphetamine use with schizophrenia in outpatients: three case reports.
Topics: Acute Disease; Adult; Ambulatory Care; Amphetamine; Dextroamphetamine; Dose-Response Relationship, D | 1974 |
Comparative psychotomimetic effects of stereoisomers of amphetamine.
Topics: Amphetamine; Behavior; Blood Pressure; Body Temperature; Dextroamphetamine; Humans; Interview, Psych | 1971 |
Stereotyped activities produced by amphetamine in several animal species and man.
Topics: Animals; Behavior, Animal; Cats; Chickens; Columbidae; Dextroamphetamine; Female; Guinea Pigs; Haplo | 1967 |
Lilliputian hallucinatiion complicatign dexamphetamine-amylobarbitone addiction.
Topics: Adolescent; Adult; Barbiturates; Dextroamphetamine; Humans; Introversion, Psychological; Male; Psych | 1968 |